| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC12A6 TRPC4AP ANO10 PKD1L2 TMEM87A ABCC6 TFRC SLC32A1 CNNM4 P2RX1 P2RX4 KCNG1 SLC18A3 GLRA2 KCNJ12 KCNJ18 ABCC2 DMAC2L SLC23A1 SLC29A1 | 2.92e-06 | 758 | 160 | 20 | GO:0015318 |
| GeneOntologyMolecularFunction | transporter activity | SLC12A6 TMEM144 TRPC4AP ABCA4 APOB ANO10 PKD1L2 TMEM87A ABCC6 CHRNE TFRC SLC32A1 CNNM4 P2RX1 P2RX4 ATAD1 KCNG1 SV2A SLC18A3 GLRA2 KCNJ12 LRP6 KCNJ18 ABCC2 DMAC2L SLC23A1 SLC29A1 | 3.95e-06 | 1289 | 160 | 27 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC12A6 TRPC4AP ANO10 PKD1L2 TMEM87A CHRNE TFRC SLC32A1 CNNM4 P2RX1 P2RX4 KCNG1 SLC18A3 KCNJ12 KCNJ18 DMAC2L SLC23A1 SLC29A1 | 6.58e-06 | 664 | 160 | 18 | GO:0008324 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC12A6 TMEM144 TRPC4AP ABCA4 ANO10 PKD1L2 TMEM87A ABCC6 CHRNE TFRC SLC32A1 CNNM4 P2RX1 P2RX4 KCNG1 SV2A SLC18A3 GLRA2 KCNJ12 LRP6 KCNJ18 ABCC2 DMAC2L SLC23A1 SLC29A1 | 7.79e-06 | 1180 | 160 | 25 | GO:0022857 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.11e-05 | 18 | 160 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC12A6 TRPC4AP ANO10 PKD1L2 TMEM87A CHRNE TFRC SLC32A1 CNNM4 P2RX1 P2RX4 KCNG1 SLC18A3 GLRA2 KCNJ12 KCNJ18 DMAC2L SLC23A1 SLC29A1 | 2.04e-05 | 793 | 160 | 19 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC12A6 TRPC4AP PKD1L2 TMEM87A TFRC SLC32A1 CNNM4 P2RX1 P2RX4 KCNG1 SLC18A3 KCNJ12 KCNJ18 DMAC2L SLC23A1 SLC29A1 | 4.56e-05 | 627 | 160 | 16 | GO:0022890 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 7.00e-05 | 28 | 160 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC12A6 TRPC4AP PKD1L2 TMEM87A TFRC CNNM4 P2RX1 P2RX4 KCNG1 KCNJ12 KCNJ18 SLC23A1 SLC29A1 | 9.85e-05 | 465 | 160 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.13e-04 | 37 | 160 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 3.84e-04 | 43 | 160 | 4 | GO:0005231 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | TRPC4AP ANO10 PKD1L2 TMEM87A CHRNE P2RX1 P2RX4 KCNG1 KCNJ12 KCNJ18 | 4.59e-04 | 343 | 160 | 10 | GO:0005261 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 9.35e-04 | 140 | 160 | 6 | GO:0099094 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 9.50e-04 | 193 | 160 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.07e-03 | 197 | 160 | 7 | GO:0022834 | |
| GeneOntologyMolecularFunction | channel activity | SLC12A6 TRPC4AP ANO10 PKD1L2 TMEM87A CHRNE P2RX1 P2RX4 KCNG1 GLRA2 KCNJ12 KCNJ18 | 1.10e-03 | 525 | 160 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SLC12A6 TRPC4AP ANO10 PKD1L2 TMEM87A CHRNE P2RX1 P2RX4 KCNG1 GLRA2 KCNJ12 KCNJ18 | 1.12e-03 | 526 | 160 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | TRPC4AP ANO10 PKD1L2 TMEM87A CHRNE P2RX1 P2RX4 KCNG1 GLRA2 KCNJ12 KCNJ18 | 1.21e-03 | 459 | 160 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | cAMP-dependent protein kinase activity | 1.31e-03 | 7 | 160 | 2 | GO:0004691 | |
| GeneOntologyMolecularFunction | extracellularly ATP-gated monoatomic cation channel activity | 1.31e-03 | 7 | 160 | 2 | GO:0004931 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.52e-03 | 334 | 160 | 9 | GO:0022836 | |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 1.73e-03 | 8 | 160 | 2 | GO:0015431 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC12A6 TRPC4AP F2RL3 ANO10 PKD1L2 CHRNE SLC32A1 CNNM4 P2RX1 P2RX4 TMEM168 KCNG1 SLC18A3 KCNJ12 PRKACA OSR1 CCR5 PLCB2 KCNJ18 ABCC2 DMAC2L SLC23A1 | 4.74e-06 | 942 | 162 | 22 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC12A6 TRPC4AP F2RL3 ANO10 PKD1L2 ABCC6 CHRNE SLC32A1 CNNM4 P2RX1 P2RX4 TMEM168 KCNG1 SLC18A3 GLRA2 KCNJ12 PRKACA OSR1 CCR5 PLCB2 KCNJ18 ABCC2 DMAC2L SLC23A1 | 6.75e-06 | 1115 | 162 | 24 | GO:0034220 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC12A6 TRPC4AP F2RL3 ANO10 PKD1L2 SLC32A1 CNNM4 P2RX1 P2RX4 TMEM168 KCNG1 SLC18A3 GLRA2 KCNJ12 PRKACA OSR1 CCR5 PLCB2 KCNJ18 ABCC2 DMAC2L SLC23A1 | 1.58e-05 | 1017 | 162 | 22 | GO:0098660 |
| GeneOntologyBiologicalProcess | interleukin-33-mediated signaling pathway | 2.59e-05 | 8 | 162 | 3 | GO:0038172 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC12A6 TRPC4AP F2RL3 ANO10 PKD1L2 CHRNE TFRC SLC32A1 CNNM4 P2RX1 P2RX4 TMEM168 KCNG1 SLC18A3 KCNJ12 PRKACA OSR1 CCR5 PLCB2 KCNJ18 ABCC2 DMAC2L SLC23A1 | 3.76e-05 | 1157 | 162 | 23 | GO:0006812 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC12A6 TRPC4AP F2RL3 PKD1L2 SLC32A1 CNNM4 P2RX1 P2RX4 TMEM168 KCNG1 SLC18A3 KCNJ12 PRKACA OSR1 CCR5 PLCB2 KCNJ18 ABCC2 DMAC2L SLC23A1 | 3.81e-05 | 922 | 162 | 20 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC12A6 TRPC4AP F2RL3 ANO10 PKD1L2 ABCC6 CHRNE TFRC SLC32A1 CNNM4 P2RX1 P2RX4 TMEM168 KCNG1 SLC18A3 GLRA2 KCNJ12 PRKACA OSR1 CCR5 PLCB2 KCNJ18 ABCC2 DMAC2L SLC23A1 | 7.11e-05 | 1374 | 162 | 25 | GO:0006811 |
| GeneOntologyCellularComponent | axoneme | 1.91e-04 | 207 | 159 | 8 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 1.97e-04 | 208 | 159 | 8 | GO:0097014 | |
| Domain | ARM-type_fold | DOCK1 DOCK3 MROH9 TRPC4AP DNAJC13 NBEAL1 USP9X RNPEPL1 APOB MEI1 TRRAP SDAD1 URB1 CSE1L PSME4 DIAPH2 UNC79 STAG3 STAG2 PPP6R3 | 1.24e-11 | 339 | 160 | 20 | IPR016024 |
| Domain | Dynein_HC_stalk | 4.86e-06 | 14 | 160 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.86e-06 | 14 | 160 | 4 | IPR013602 | |
| Domain | DHC_N2 | 4.86e-06 | 14 | 160 | 4 | PF08393 | |
| Domain | MT | 4.86e-06 | 14 | 160 | 4 | PF12777 | |
| Domain | DHC_fam | 6.58e-06 | 15 | 160 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 6.58e-06 | 15 | 160 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 6.58e-06 | 15 | 160 | 4 | IPR004273 | |
| Domain | AAA | 3.42e-05 | 144 | 160 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 3.42e-05 | 144 | 160 | 8 | IPR003593 | |
| Domain | K_chnl_inward-rec_Kir2.2 | 7.29e-05 | 2 | 160 | 2 | IPR003272 | |
| Domain | ARM-like | MROH9 DNAJC13 USP9X MEI1 TRRAP CSE1L PSME4 STAG3 STAG2 PPP6R3 | 1.15e-04 | 270 | 160 | 10 | IPR011989 |
| Domain | Dynein_heavy_chain_D4_dom | 2.10e-04 | 14 | 160 | 3 | IPR024317 | |
| Domain | AAA_8 | 2.10e-04 | 14 | 160 | 3 | PF12780 | |
| Domain | K_chnl_inward-rec_Kir_N | 2.18e-04 | 3 | 160 | 2 | IPR013673 | |
| Domain | IRK_N | 2.18e-04 | 3 | 160 | 2 | PF08466 | |
| Domain | SCD | 4.33e-04 | 4 | 160 | 2 | PS51425 | |
| Domain | SCD | 4.33e-04 | 4 | 160 | 2 | IPR020839 | |
| Domain | STAG | 4.33e-04 | 4 | 160 | 2 | PF08514 | |
| Domain | STAG | 4.33e-04 | 4 | 160 | 2 | IPR013721 | |
| Domain | Multidrug-R_assoc | 4.33e-04 | 4 | 160 | 2 | IPR005292 | |
| Domain | DOCK_N | 7.17e-04 | 5 | 160 | 2 | PF16172 | |
| Domain | DOCK_N | 7.17e-04 | 5 | 160 | 2 | IPR032376 | |
| Domain | P2X_receptor | 1.49e-03 | 7 | 160 | 2 | PF00864 | |
| Domain | STAT_TF_DNA-bd_sub | 1.49e-03 | 7 | 160 | 2 | IPR012345 | |
| Domain | STAT | 1.49e-03 | 7 | 160 | 2 | IPR001217 | |
| Domain | P2X_purnocptor | 1.49e-03 | 7 | 160 | 2 | IPR001429 | |
| Domain | STAT_int | 1.49e-03 | 7 | 160 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 1.49e-03 | 7 | 160 | 2 | IPR013801 | |
| Domain | STAT_bind | 1.49e-03 | 7 | 160 | 2 | PF02864 | |
| Domain | STAT_int | 1.49e-03 | 7 | 160 | 2 | PF02865 | |
| Domain | - | 1.49e-03 | 7 | 160 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 1.49e-03 | 7 | 160 | 2 | PF01017 | |
| Domain | - | 1.49e-03 | 7 | 160 | 2 | 2.60.490.10 | |
| Domain | - | 1.49e-03 | 7 | 160 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 1.49e-03 | 7 | 160 | 2 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 1.49e-03 | 7 | 160 | 2 | IPR015988 | |
| Domain | - | 1.49e-03 | 7 | 160 | 2 | 2.60.40.630 | |
| Domain | P2X_RECEPTOR | 1.49e-03 | 7 | 160 | 2 | PS01212 | |
| Domain | P2X_extracellular_dom | 1.49e-03 | 7 | 160 | 2 | IPR027309 | |
| Domain | STAT_TF_alpha | 1.97e-03 | 8 | 160 | 2 | IPR013800 | |
| Domain | DHC_N1 | 1.97e-03 | 8 | 160 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.97e-03 | 8 | 160 | 2 | IPR013594 | |
| Domain | - | 3.07e-03 | 222 | 160 | 7 | 1.25.10.10 | |
| Domain | GPS | 3.30e-03 | 35 | 160 | 3 | PF01825 | |
| Domain | GPS | 3.58e-03 | 36 | 160 | 3 | PS50221 | |
| Domain | DHR-1_domain | 3.81e-03 | 11 | 160 | 2 | IPR027007 | |
| Domain | DHR_2 | 3.81e-03 | 11 | 160 | 2 | PS51651 | |
| Domain | DHR_1 | 3.81e-03 | 11 | 160 | 2 | PS51650 | |
| Domain | DHR-2 | 3.81e-03 | 11 | 160 | 2 | PF06920 | |
| Domain | DOCK | 3.81e-03 | 11 | 160 | 2 | IPR026791 | |
| Domain | DOCK_C | 3.81e-03 | 11 | 160 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 3.81e-03 | 11 | 160 | 2 | PF14429 | |
| Domain | DHR-2 | 3.81e-03 | 11 | 160 | 2 | IPR027357 | |
| Domain | GPS | 3.87e-03 | 37 | 160 | 3 | IPR000203 | |
| Domain | ABC_transporter_CS | 5.55e-03 | 42 | 160 | 3 | IPR017871 | |
| Domain | ATPase_dyneun-rel_AAA | 6.20e-03 | 14 | 160 | 2 | IPR011704 | |
| Domain | AAA_5 | 6.20e-03 | 14 | 160 | 2 | PF07728 | |
| Domain | ABC_tran | 8.05e-03 | 48 | 160 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 8.05e-03 | 48 | 160 | 3 | PS50893 | |
| Domain | IRK | 8.09e-03 | 16 | 160 | 2 | PF01007 | |
| Domain | K_chnl_inward-rec_Kir_cyto | 8.09e-03 | 16 | 160 | 2 | IPR013518 | |
| Domain | - | 8.09e-03 | 16 | 160 | 2 | 2.60.40.1400 | |
| Domain | K_chnl_inward-rec_Kir | 8.09e-03 | 16 | 160 | 2 | IPR016449 | |
| Domain | ABC_TRANSPORTER_1 | 8.52e-03 | 49 | 160 | 3 | PS00211 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NAT14 CLGN EMC1 DYNC2H1 USP9X PSMC3 LRRC59 URB2 TFRC FANCD2 CNNM4 URB1 CSE1L NUP155 ATAD1 PXMP2 GEMIN4 LRP6 STAG2 PPP6R3 | 2.54e-08 | 942 | 165 | 20 | 31073040 |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 3.37e-08 | 8 | 165 | 4 | 12634303 | |
| Pubmed | PI4K2B CLGN EMC1 DDX60 UGGT1 VPS8 PSMC3 LRRC59 TUBGCP4 SDAD1 TFRC FANCD2 CNNM4 UBE4A URB1 MAP7D1 CSE1L NUP155 ATAD1 GEMIN4 PSME3 STAG2 PPP6R3 ZC3HAV1 | 9.06e-08 | 1440 | 165 | 24 | 30833792 | |
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 18552213 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | TRPC4AP CLGN EMC1 PPFIA1 UGGT1 PSMC3 LCP1 TFRC FANCD2 CNNM4 MAP7D1 CSE1L NUP155 XRN1 GEMIN4 C3 PSME3 PPP6R3 ZC3HAV1 | 2.14e-07 | 974 | 165 | 19 | 28675297 |
| Pubmed | EMC1 ITSN1 GART PSMC3 LRRC59 TMEM87A STAT5A TFRC UBE4A CSE1L NUP155 XRN1 ZC3HAV1 | 2.62e-07 | 449 | 165 | 13 | 31732153 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DNHD1 EMC1 DYNC2H1 USP9X UGGT1 GART PSMC3 BCCIP APOB LRRC59 URB2 SDAD1 TFRC FANCD2 UBE4A URB1 CSE1L NUP155 PRKACA GEMIN4 PSME3 STAG2 ZC3HAV1 | 3.04e-07 | 1425 | 165 | 23 | 30948266 |
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 22059479 | ||
| Pubmed | USP9X UGGT1 GART PSMC3 URB2 LCP1 TRRAP URB1 CSE1L NUP155 XRN1 GEMIN4 STAG2 PPP6R3 ZC3HAV1 | 5.88e-07 | 653 | 165 | 15 | 22586326 | |
| Pubmed | MMS22L CLGN EMC1 USP9X GART PSMC3 TUBGCP4 TFRC FANCD2 MAP7D1 CSE1L PRKACA GEMIN4 PPP6R3 ZC3HAV1 | 6.35e-07 | 657 | 165 | 15 | 36180527 | |
| Pubmed | CLGN USP9X GART PSMC3 TUBGCP4 TFRC URB1 CSE1L PRKACA GEMIN4 PSME3 ZC3HAV1 | 6.51e-07 | 408 | 165 | 12 | 33766124 | |
| Pubmed | Stat5 expression is critical for mast cell development and survival. | 2.08e-06 | 6 | 165 | 3 | 12714518 | |
| Pubmed | Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5. | 2.08e-06 | 6 | 165 | 3 | 19647226 | |
| Pubmed | DNAJC13 EMC1 DSC3 USP9X PPFIA1 UGGT1 PSMC3 SDAD1 FANCD2 CNNM4 CSE1L NUP155 PTPRZ1 PRKACA LRP6 CDK5RAP2 SLC29A1 PPP6R3 | 2.81e-06 | 1049 | 165 | 18 | 27880917 | |
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 16286016 | ||
| Pubmed | PPFIA1 ITSN1 UGGT1 LGR4 NFKBIZ APOB ST3GAL2 URB1 PSME4 P2RX4 SYNJ1 IRAK4 NFYC CDK5RAP2 KLHDC10 SLC29A1 STAG2 VPS13B | 4.42e-06 | 1084 | 165 | 18 | 11544199 | |
| Pubmed | Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. | 5.72e-06 | 25 | 165 | 4 | 19898481 | |
| Pubmed | SLC12A6 DNAJC13 EMC1 VPS8 TMEM87A NUP155 SV2A MTFR1 DIAPH2 SLC29A1 VPS13B ZC3HAV1 | 5.74e-06 | 504 | 165 | 12 | 34432599 | |
| Pubmed | Genetic analysis of Down syndrome-associated heart defects in mice. | 5.77e-06 | 8 | 165 | 3 | 21442329 | |
| Pubmed | 9.64e-06 | 285 | 165 | 9 | 34369648 | ||
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | PPFIA1 BCCIP TRRAP SDAD1 FANCD2 KLHL9 NUP155 MTFR1 PSME3 ZC3HAV1 | 1.04e-05 | 364 | 165 | 10 | 24778252 |
| Pubmed | PI4K2B DNAJC13 USP9X PSMC3 LRRC59 ANO10 TUBGCP4 CSE1L NUP155 P2RX4 ATAD1 XRN1 PXMP2 GEMIN4 PARP9 PSME3 SLC29A1 STAG2 | 1.21e-05 | 1168 | 165 | 18 | 19946888 | |
| Pubmed | Stat5 regulates cellular iron uptake of erythroid cells via IRP-2 and TfR-1. | 1.23e-05 | 10 | 165 | 3 | 18694996 | |
| Pubmed | DNAJC13 USP9X GART PSMC3 LRRC59 TFRC CSE1L NUP155 GEMIN4 PSME3 STAG2 PPP6R3 ZC3HAV1 | 1.23e-05 | 638 | 165 | 13 | 33239621 | |
| Pubmed | DNAJC13 EMC1 PPFIA1 UGGT1 GART PSMC3 LGR4 BCCIP APOB LRRC59 URB2 TRRAP TFRC NUP155 PRKACA C3 KLHDC10 PPP6R3 ZC3HAV1 | 1.39e-05 | 1297 | 165 | 19 | 33545068 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.78e-05 | 235 | 165 | 8 | 30258100 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | USP9X PSMC3 LRRC59 TBC1D24 TFRC FANCD2 URB1 CSE1L NUP155 PRKACA PSME3 PPP6R3 | 1.98e-05 | 571 | 165 | 12 | 37167062 |
| Pubmed | Roles of BLOC-1 and adaptor protein-3 complexes in cargo sorting to synaptic vesicles. | 2.24e-05 | 12 | 165 | 3 | 19144828 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 23151802 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 26999798 | ||
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 2.24e-05 | 2 | 165 | 2 | 31443474 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 12377952 | ||
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 2.24e-05 | 2 | 165 | 2 | 21127177 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 16289657 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 25552366 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 25470773 | ||
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 2.24e-05 | 2 | 165 | 2 | 21431790 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 28500076 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 21826656 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 7720707 | ||
| Pubmed | STAT5A and STAT5B have opposite correlations with drug response gene expression. | 2.24e-05 | 2 | 165 | 2 | 27264955 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 22159083 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 24845338 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 20008792 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 33199496 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 18562603 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 16502315 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 12217382 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 31599926 | ||
| Pubmed | Proteasome activators, PA28γ and PA200, play indispensable roles in male fertility. | 2.24e-05 | 2 | 165 | 2 | 27003159 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 10594041 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 17934511 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 21036145 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 10486277 | ||
| Pubmed | Identification of human STAT5-dependent gene regulatory elements based on interspecies homology. | 2.24e-05 | 2 | 165 | 2 | 16840779 | |
| Pubmed | The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. | 2.24e-05 | 2 | 165 | 2 | 15128421 | |
| Pubmed | STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. | 2.24e-05 | 2 | 165 | 2 | 30377054 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 23565285 | ||
| Pubmed | Characterization and mechanism of P2X receptor-mediated increase in cardiac myocyte contractility. | 2.24e-05 | 2 | 165 | 2 | 17873021 | |
| Pubmed | Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. | 2.24e-05 | 2 | 165 | 2 | 32790723 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 18492722 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 10066807 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 10835485 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 35464049 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 18286195 | ||
| Pubmed | Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. | 2.24e-05 | 2 | 165 | 2 | 23773921 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 8631883 | ||
| Pubmed | Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. | 2.24e-05 | 2 | 165 | 2 | 11030348 | |
| Pubmed | Association between STAT5 polymorphisms and glioblastoma risk in Han Chinese population. | 2.24e-05 | 2 | 165 | 2 | 24878107 | |
| Pubmed | Role of Kir2.2 in hypercapnic ventilatory response during postnatal development of mouse. | 2.24e-05 | 2 | 165 | 2 | 15705530 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 12847485 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 12835478 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 7568026 | ||
| Pubmed | Identification of STAT5A and STAT5B target genes in human T cells. | 2.24e-05 | 2 | 165 | 2 | 24497979 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 17536022 | ||
| Pubmed | STAT5 transcriptional activity is impaired by LIF in a mammary epithelial cell line. | 2.24e-05 | 2 | 165 | 2 | 17382296 | |
| Pubmed | STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation. | 2.24e-05 | 2 | 165 | 2 | 17911616 | |
| Pubmed | STAT5 signaling in sexually dimorphic gene expression and growth patterns. | 2.24e-05 | 2 | 165 | 2 | 10486314 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 17599554 | ||
| Pubmed | MiR-21 is under control of STAT5 but is dispensable for mammary development and lactation. | 2.24e-05 | 2 | 165 | 2 | 24497923 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 24335105 | ||
| Pubmed | Brain STAT5 signaling modulates learning and memory formation. | 2.24e-05 | 2 | 165 | 2 | 29460051 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 28606561 | ||
| Pubmed | Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells. | 2.24e-05 | 2 | 165 | 2 | 12393407 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 12039059 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 21178171 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 20591207 | ||
| Pubmed | Immune complex-induced integrin activation and L-plastin phosphorylation require protein kinase A. | 2.24e-05 | 2 | 165 | 2 | 10446213 | |
| Pubmed | Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. | 2.24e-05 | 2 | 165 | 2 | 20233708 | |
| Pubmed | Involvement of the STAT5 signaling pathway in the regulation of mouse preimplantation development. | 2.24e-05 | 2 | 165 | 2 | 16775227 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 17447893 | ||
| Pubmed | Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma. | 2.24e-05 | 2 | 165 | 2 | 27500726 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 9325061 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 16115927 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 15039079 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 23275557 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 11867689 | ||
| Pubmed | Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes. | 2.24e-05 | 2 | 165 | 2 | 15980098 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 15340066 | ||
| Pubmed | STAT5A/B gene locus undergoes amplification during human prostate cancer progression. | 2.24e-05 | 2 | 165 | 2 | 23660011 | |
| Interaction | P2RY6 interactions | CLGN EMC1 UGGT1 VPS8 PSMC3 LRRC59 TUBGCP4 TFRC FANCD2 CNNM4 UBE4A CSE1L NUP155 GEMIN4 PPP6R3 | 5.35e-07 | 385 | 162 | 15 | int:P2RY6 |
| Interaction | ANKRD20A4P interactions | 1.00e-05 | 6 | 162 | 3 | int:ANKRD20A4P | |
| Interaction | S1PR4 interactions | 1.52e-05 | 137 | 162 | 8 | int:S1PR4 | |
| Interaction | ANKRD20A2P interactions | 1.74e-05 | 7 | 162 | 3 | int:ANKRD20A2P | |
| Interaction | GPR17 interactions | MMS22L VPS8 TUBGCP4 TMEM87A FANCD2 UBE4A URB1 CSE1L GEMIN4 SLC29A1 STAG2 | 1.89e-05 | 283 | 162 | 11 | int:GPR17 |
| Interaction | TLR9 interactions | 3.13e-05 | 75 | 162 | 6 | int:TLR9 | |
| Interaction | UNC93B1 interactions | CLGN EMC1 UGGT1 VPS8 PSMC3 LRRC59 TFRC FANCD2 CNNM4 CSE1L ATAD1 GEMIN4 STAG2 | 3.38e-05 | 417 | 162 | 13 | int:UNC93B1 |
| Cytoband | 2q11.1 | 1.40e-04 | 28 | 165 | 3 | 2q11.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q11 | 2.40e-04 | 153 | 165 | 5 | chr2q11 | |
| GeneFamily | Purinergic receptors P2X | 7.15e-04 | 7 | 107 | 2 | 214 | |
| GeneFamily | Cohesin complex | 9.49e-04 | 8 | 107 | 2 | 1060 | |
| Coexpression | GSE14308_TH2_VS_NAIVE_CD4_TCELL_DN | DYNC2H1 TRRAP FBXO46 VSIR STAT5A CSE1L PARP9 TMEM35A STAG2 VPS13B | 5.35e-07 | 200 | 163 | 10 | M3365 |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_DN | TTC39B TRAF6 TRPC4AP ZBTB20 NBEAL1 DNAH7 ADH1C IRAK4 XRN1 DIAPH2 | 5.35e-07 | 200 | 163 | 10 | M5697 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | DOCK3 MMS22L NAT14 TBC1D24 FANCD2 TMEM130 NUP155 PTPRZ1 CENPI SASS6 CDK5RAP2 KLHDC10 UNC79 SCAI REV1 | 2.41e-05 | 680 | 163 | 15 | MM456 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK1 DNAJC13 ZBTB20 USP9X PPFIA1 ITSN1 CAV2 TRRAP ZNF804A TMEM87A CSE1L PSME4 MTFR1 NFYC KLHDC10 STAG2 VPS13B | 2.60e-05 | 856 | 163 | 17 | M4500 |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_UP | 3.78e-05 | 200 | 163 | 8 | M9900 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 2.18e-08 | 177 | 165 | 9 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.06e-07 | 199 | 165 | 8 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-HSC/ELP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.63e-06 | 152 | 165 | 7 | f2cedf16e826aad763bfee5e46444327482f9a53 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.69e-06 | 172 | 165 | 7 | 7e1a7700a4c2b1d100da1d6e475e73498ebb605a | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-06 | 176 | 165 | 7 | 3766e0533b103ec92ac75eba3df02e287efc53fa | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-06 | 176 | 165 | 7 | aa1bada2175d8370fc71939a607407155259d195 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 4.30e-06 | 176 | 165 | 7 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 5.55e-06 | 183 | 165 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P ADRA2B ANKRD20A4P FHIP1A ANKRD20A1 | 5.75e-06 | 184 | 165 | 7 | c6affa0b12510363258f65e46bf2d47bf4a8e75f |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 5.96e-06 | 185 | 165 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 6.17e-06 | 186 | 165 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.40e-06 | 187 | 165 | 7 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.40e-06 | 187 | 165 | 7 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Myeloid|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 8.13e-06 | 194 | 165 | 7 | 4f28841c7f37884fc34c6689cd6976c6559d23f1 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Myeloid-Microglia|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 8.13e-06 | 194 | 165 | 7 | 459e836bcdb6742333684ac23d960efa5e99702f | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 9.28e-06 | 198 | 165 | 7 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 9.28e-06 | 198 | 165 | 7 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-05 | 149 | 165 | 6 | 5a5e9660f7d9b527f50a92d94d4c0c8aedb82c0b | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.05e-05 | 150 | 165 | 6 | 57f21ad380fd1350a2c25d75ad8c3b763ded53ec | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.75e-05 | 158 | 165 | 6 | 91d8c93af328c3bbebe1d8f019b94849ebc548c0 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 160 | 165 | 6 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.28e-05 | 163 | 165 | 6 | ec9a20cfe0d69430f9c68cddd1ab0e4a3e4554b8 | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.39e-05 | 164 | 165 | 6 | 95b800c78871354c859abaa832d778786ef7bcc0 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-05 | 166 | 165 | 6 | 8e5a262dc4f04c5fc75b9a7a907832a0d7877df0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.01e-05 | 169 | 165 | 6 | b2fdf9f842dc7c181bc951a8a6932c916ed835ef | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.01e-05 | 169 | 165 | 6 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.01e-05 | 169 | 165 | 6 | 2322f03a115c662f808ebfc892192b7d38d48181 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.15e-05 | 170 | 165 | 6 | 14aa86a4f526ed6986afcb28c49225522055550c | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 170 | 165 | 6 | dbd6c9c7be824a1ff1b31af791064127cafbd194 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.28e-05 | 171 | 165 | 6 | 5efd15300f865ebf651e0888265cbd717bc3b9d3 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 171 | 165 | 6 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 171 | 165 | 6 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Mast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.43e-05 | 172 | 165 | 6 | a7146c255031207e64682ef767884b11c96e0d59 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.72e-05 | 174 | 165 | 6 | a5f2a4e3b25e6084bd7003a53da86a44f6fcf294 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 174 | 165 | 6 | 8d6df5938cef542f23259ce471eea1a1afbed03c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 174 | 165 | 6 | 2af54c3427aacfa232e2aca6003b4a8ecb8bba66 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 174 | 165 | 6 | eca643b8f5b92aeed5a77c94b4301fd8100f9401 | |
| ToppCell | COVID-19_Mild-Neu_3|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 5.03e-05 | 176 | 165 | 6 | 2049767fd591045cfcf5b1071d80798e52843f27 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.03e-05 | 176 | 165 | 6 | 05ec715439f2eb1696f5d8855da0dd1dd70effd0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-05 | 178 | 165 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-05 | 180 | 165 | 6 | 7368ab31c3273374ef260f0d710d4eea83cbc4a2 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 182 | 165 | 6 | 751bd3e3b49de961523e98197688a05c998c121a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.06e-05 | 182 | 165 | 6 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-pre-pDC/DC5|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.06e-05 | 182 | 165 | 6 | fec8a2d6d4099722b8e1bb41222108ed74268fcf | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.06e-05 | 182 | 165 | 6 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| ToppCell | wk_15-18-Hematologic-Myeloid-MEP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.44e-05 | 184 | 165 | 6 | 19d61d0ab038b7e729e13a46f88b8cf31759485d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-05 | 184 | 165 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-05 | 184 | 165 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-05 | 184 | 165 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.63e-05 | 185 | 165 | 6 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.63e-05 | 185 | 165 | 6 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.63e-05 | 185 | 165 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.63e-05 | 185 | 165 | 6 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.63e-05 | 185 | 165 | 6 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | HSPCs-Eo/Baso_prog.|World / Lineage and Cell class | 6.63e-05 | 185 | 165 | 6 | b40ea11f5e536438b400ca5fddfd4559789036bd | |
| ToppCell | tumor_Lung-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 6.83e-05 | 186 | 165 | 6 | 3d7c1a281fb82db4471283f39937007d889a5f38 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.83e-05 | 186 | 165 | 6 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.83e-05 | 186 | 165 | 6 | 8694ca16c9780729f4fba67ba20e35745f1eb4e9 | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P ADRA2B ANKRD20A4P ANKRD20A1 | 6.83e-05 | 186 | 165 | 6 | b05c394aa3573ba855abc3066739ca193883b0c3 |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.25e-05 | 188 | 165 | 6 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-T_&_ILC-ILC2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.46e-05 | 189 | 165 | 6 | 9c963f525ae765499b3e3229fead3aef018345ef | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 7.91e-05 | 191 | 165 | 6 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 7.91e-05 | 191 | 165 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.91e-05 | 191 | 165 | 6 | 47f20686001f945bc31d5a0b974958e4009edb34 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 8.37e-05 | 193 | 165 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | control-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.62e-05 | 194 | 165 | 6 | 267e213e8efe53aadfe553a2ca010a0e3b4b8939 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.86e-05 | 195 | 165 | 6 | 0fbba312e9ba9b70b4b814b67b6eb1f6544aaf6d | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.37e-05 | 197 | 165 | 6 | 8b9a88fb671d5c2b25d291c851e2b8a478f2610c | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.37e-05 | 197 | 165 | 6 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 9.64e-05 | 198 | 165 | 6 | 880f9817f5145f10f29fc05c5866090433532fe2 | |
| ToppCell | distal-Epithelial-Ciliated-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.64e-05 | 198 | 165 | 6 | d30d6c6a0a78b7571318b5b2a0186df96dd0f5a9 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.91e-05 | 199 | 165 | 6 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.91e-05 | 199 | 165 | 6 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 165 | 6 | 0eccf41edefc3b8b5d0316f57d5ba572949aec2b | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 200 | 165 | 6 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Mesenchymal-BMP_responsible_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 165 | 6 | cd0d69f973ca3204b500d12031b403a1f4593431 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 165 | 6 | aafe594c88710f8c53d59667cdac5035e08f5511 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 165 | 6 | fe22f7c97f4e37dfa7881d0f1d9245c1237d873b | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 200 | 165 | 6 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-04 | 200 | 165 | 6 | 80e0483d5ab0c6213aae0ec62619f57e6ec0e4c2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 165 | 6 | a6f0f5f644b7262878b0b9d4d90ee407c4124dd9 | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 1.07e-04 | 126 | 165 | 5 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Vip_(ventral_GP_(vGP))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.18e-04 | 68 | 165 | 4 | ad6c363d7fb3c436e894db30a544748c5df75a45 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Vip_(ventral_GP_(vGP))--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.18e-04 | 68 | 165 | 4 | 82d928f5eefa065d26096a84b0d78f131dcc8c73 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Vip_(ventral_GP_(vGP))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.18e-04 | 68 | 165 | 4 | d97199a8c6afa79bff1600f00c2dbf6286df24a2 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-pDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-04 | 129 | 165 | 5 | 454bae525f6db3d0dd6347d2a2c3ea9dda9cd212 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-04 | 131 | 165 | 5 | cc5b5afab8622e98f673fa116a226d930c295327 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.32e-04 | 70 | 165 | 4 | 986c7a1002a4ffd3a246495bedde2997ffdc2c9d | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.32e-04 | 70 | 165 | 4 | c0330216305491d7d57cdbea0ae3cb8e9092c8e3 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P3|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.32e-04 | 70 | 165 | 4 | 86dde790fcdaec2095e2256463953077811145d2 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.32e-04 | 70 | 165 | 4 | e604660b2efbc03e21806dcaecf7a72321673ae2 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Mme_Fam114a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.37e-04 | 133 | 165 | 5 | fc319644868078ea0f88a71d55f5e858c6848b50 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Sema3e|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.56e-04 | 73 | 165 | 4 | 51bcbb57ee6c45cad88cb3e2cedab2cf3503b2a5 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.58e-04 | 137 | 165 | 5 | d346086f42d8f04d3fa67fe696834284acdc7080 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6_(Thalamus,_glutamatergic)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.64e-04 | 74 | 165 | 4 | ef4c9eafc794c7d50aef28b37d21b52d3c511499 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6_(Thalamus,_glutamatergic)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.64e-04 | 74 | 165 | 4 | 6ecbdf4186039a031410e09ecd5afa66b6d5e2dc | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.92e-04 | 77 | 165 | 4 | 10969743351c49a1d6d8ae1ef93098e7786ca3fe | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.99e-04 | 144 | 165 | 5 | 7de962346ba9653d90dd13bb7d977fe44d200bba | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.06e-04 | 145 | 165 | 5 | 88e463d5396a8fea2b7b1ecf3c9b144e16b35234 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.06e-04 | 145 | 165 | 5 | 911fee7f27694393e348d94470a1a4e890038902 | |
| Computational | Genes in the cancer module 267. | 1.08e-05 | 15 | 105 | 4 | MODULE_267 | |
| Drug | ICI 182,780; Down 200; 1uM; ssMCF7; HG-U133A | 1.48e-06 | 196 | 162 | 10 | 523_DN | |
| Drug | Estropipate [7280-37-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.55e-06 | 197 | 162 | 10 | 6068_UP | |
| Drug | Isoxicam [34552-84-6]; Down 200; 12uM; MCF7; HT_HG-U133A | TRAF6 DYNC2H1 ITSN1 STAT5B PRKACA IRAK4 KLHDC10 DMAC2L SLC29A1 PPP6R3 | 1.62e-06 | 198 | 162 | 10 | 7028_DN |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; HL60; HT_HG-U133A | 1.22e-05 | 197 | 162 | 9 | 2439_DN | |
| Drug | vinblastine sulfate; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.27e-05 | 198 | 162 | 9 | 7556_DN | |
| Drug | Cefoperazone dihydrate; Down 200; 5.8uM; HL60; HG-U133A | 1.33e-05 | 199 | 162 | 9 | 1627_DN | |
| Disease | mean corpuscular hemoglobin concentration | ADGRG5 DNAJC13 RNPEPL1 ITSN1 BCCIP GON4L URB2 LCP1 TFRC CNTN5 KCNJ12 PARP9 ZDHHC19 SLC23A1 SLC29A1 VPS13B PPP6R3 | 8.81e-05 | 1105 | 157 | 17 | EFO_0004528 |
| Disease | adipose tissue measurement | 9.70e-05 | 45 | 157 | 4 | EFO_0004764 | |
| Disease | autosomal recessive polycystic kidney disease (is_marker_for) | 1.68e-04 | 4 | 157 | 2 | DOID:0110861 (is_marker_for) | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 3.60e-04 | 63 | 157 | 4 | EFO_0001645, EFO_0004792 | |
| Disease | Carcinoma, Lobular | 4.16e-04 | 6 | 157 | 2 | C0206692 | |
| Disease | gastric adenocarcinoma (is_marker_for) | 4.39e-04 | 28 | 157 | 3 | DOID:3717 (is_marker_for) | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 5.68e-04 | 71 | 157 | 4 | EFO_0001645, EFO_0004791 | |
| Disease | Helicobacter Infections | 5.80e-04 | 7 | 157 | 2 | C0079487 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 5.95e-04 | 31 | 157 | 3 | EFO_0022249 | |
| Disease | triacylglycerol 54:5 measurement | 6.54e-04 | 32 | 157 | 3 | EFO_0010423 | |
| Disease | polyunsaturated fatty acid measurement | 6.95e-04 | 131 | 157 | 5 | EFO_0010733 | |
| Disease | anterior uveitis (biomarker_via_orthology) | 9.88e-04 | 9 | 157 | 2 | DOID:1407 (biomarker_via_orthology) | |
| Disease | kynurenine measurement | 1.17e-03 | 39 | 157 | 3 | EFO_0008529 | |
| Disease | mean reticulocyte volume | ADGRG5 RNPEPL1 ITSN1 GRB10 URB2 LCP1 TRRAP TBC1D24 TFRC CNTN5 SLC29A1 STAG2 | 1.22e-03 | 799 | 157 | 12 | EFO_0010701 |
| Disease | level of Triacylglycerol (51:3) in blood serum | 1.23e-03 | 10 | 157 | 2 | OBA_2045163 | |
| Disease | Combined immunodeficiency | 1.36e-03 | 41 | 157 | 3 | C0494261 | |
| Disease | Colorectal Carcinoma | ABCA4 RNPEPL1 ASAP3 APOB ZNF804A ABCC6 TFRC CSE1L ATAD1 ABCC2 SLC29A1 | 1.39e-03 | 702 | 157 | 11 | C0009402 |
| Disease | PARKINSON DISEASE, LATE-ONSET | 1.79e-03 | 12 | 157 | 2 | C3160718 | |
| Disease | integral membrane protein 2B measurement | 1.79e-03 | 12 | 157 | 2 | EFO_0802634 | |
| Disease | rhinitis (is_marker_for) | 1.90e-03 | 46 | 157 | 3 | DOID:4483 (is_marker_for) | |
| Disease | Primary Ciliary Dyskinesia | 2.02e-03 | 47 | 157 | 3 | C4551720 | |
| Disease | gastroesophageal reflux disease | 2.11e-03 | 101 | 157 | 4 | EFO_0003948 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 2.11e-03 | 13 | 157 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | gallbladder cancer (is_implicated_in) | 2.11e-03 | 13 | 157 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | brain ischemia (biomarker_via_orthology) | 2.19e-03 | 102 | 157 | 4 | DOID:2316 (biomarker_via_orthology) | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 2.28e-03 | 49 | 157 | 3 | EFO_0022256 | |
| Disease | lipoprotein measurement | 2.43e-03 | 105 | 157 | 4 | EFO_0004732 | |
| Disease | low density lipoprotein triglyceride measurement | 2.82e-03 | 15 | 157 | 2 | EFO_0009946 | |
| Disease | triacylglycerol 52:3 measurement | 2.82e-03 | 15 | 157 | 2 | EFO_0010415 | |
| Disease | Autosomal recessive primary microcephaly | 2.82e-03 | 15 | 157 | 2 | cv:C3711387 | |
| Disease | coronary artery disease, factor VII measurement | 2.97e-03 | 111 | 157 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | triglycerides in very large HDL measurement | 3.17e-03 | 55 | 157 | 3 | EFO_0022324 | |
| Disease | factor VIII measurement, coronary artery disease | 3.17e-03 | 113 | 157 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 3.21e-03 | 16 | 157 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | sickle cell anemia (is_implicated_in) | 3.21e-03 | 16 | 157 | 2 | DOID:10923 (is_implicated_in) | |
| Disease | glomerulonephritis (implicated_via_orthology) | 3.63e-03 | 17 | 157 | 2 | DOID:2921 (implicated_via_orthology) | |
| Disease | total lipids in medium HDL measurement | 3.68e-03 | 58 | 157 | 3 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 3.68e-03 | 58 | 157 | 3 | EFO_0022267 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 3.70e-03 | 118 | 157 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | glycoprotein measurement | 3.81e-03 | 119 | 157 | 4 | EFO_0004555 | |
| Disease | cholesterol in medium HDL measurement | 3.86e-03 | 59 | 157 | 3 | EFO_0021903 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.97e-03 | 195 | 157 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 4.05e-03 | 121 | 157 | 4 | EFO_0004612, EFO_0005271 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 4.05e-03 | 60 | 157 | 3 | EFO_0022237 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 4.05e-03 | 60 | 157 | 3 | EFO_0022282 | |
| Disease | Age-related macular degeneration | 4.07e-03 | 18 | 157 | 2 | cv:C0242383 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 4.07e-03 | 18 | 157 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 4.15e-03 | 197 | 157 | 5 | EFO_0005680 | |
| Disease | free cholesterol in HDL measurement | 4.24e-03 | 61 | 157 | 3 | EFO_0022264 | |
| Disease | phospholipids in HDL measurement | 4.24e-03 | 61 | 157 | 3 | EFO_0022293 | |
| Disease | free cholesterol in very large HDL measurement | 4.44e-03 | 62 | 157 | 3 | EFO_0022273 | |
| Disease | angina pectoris | 4.54e-03 | 125 | 157 | 4 | EFO_0003913 | |
| Disease | total lipids in HDL measurement | 4.65e-03 | 63 | 157 | 3 | EFO_0022307 | |
| Disease | juvenile dermatomyositis | 5.02e-03 | 20 | 157 | 2 | EFO_0000557 | |
| Disease | IgA glomerulonephritis (is_marker_for) | 5.02e-03 | 20 | 157 | 2 | DOID:2986 (is_marker_for) | |
| Disease | platelet crit | ADGRG5 ZBTB20 RNPEPL1 APOB ST7L CHRNE OR14A2 P2RX1 CNTN5 POLR1B FHIP1A ZC3HAV1 | 5.06e-03 | 952 | 157 | 12 | EFO_0007985 |
| Disease | choline measurement | 5.22e-03 | 130 | 157 | 4 | EFO_0010116 | |
| Disease | total lipids in very large HDL measurement | 5.29e-03 | 66 | 157 | 3 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 5.29e-03 | 66 | 157 | 3 | EFO_0022298 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LKAIPSFLNSFNRLV | 1386 | Q14146 | |
| ALDKDNNTPLLFAII | 161 | Q5TYW2 | |
| KAAQSLFPFIEKLAA | 231 | Q8TDY4 | |
| ALDKDSNTPLLFAII | 161 | Q5CZ79 | |
| ANVDFFKLFRVLPTL | 246 | P78363 | |
| KDFLAQIVLPATFVF | 1371 | P78363 | |
| ALDKDNNTPLLFAII | 161 | Q4UJ75 | |
| FSLDALITNILPFEK | 341 | P00326 | |
| TKALLAFAIPAFVIV | 556 | Q8IZF3 | |
| IDLALPFAILLGFTN | 296 | P50052 | |
| VLIFANKQDLLTAAP | 121 | P36405 | |
| ALLALLQLKDFDFVP | 1236 | P01024 | |
| PTLKDIFLAVENALL | 316 | Q96DT5 | |
| PQNLFLVSLAAADIL | 46 | P18089 | |
| KAFLEPLSQLQVADF | 3226 | Q96M86 | |
| NLAISDLFFLLTVPF | 71 | P51681 | |
| ENPDLFAKLALNFAT | 666 | O60879 | |
| NLVQAFKTALPSLEL | 196 | Q99766 | |
| FLFLIAQKIPETSLS | 286 | Q04844 | |
| GAFINLLAPLFNEKA | 771 | Q96SN8 | |
| LFPETTANFDKLLIQ | 401 | Q8IYR0 | |
| AELKILASAPTFALN | 471 | O94779 | |
| TLNLFQHLPELKSFF | 2301 | Q6ZS30 | |
| PAFLKAAENFTLLVK | 176 | Q99571 | |
| SLSLLFQKVFAQIFP | 21 | Q8IXQ6 | |
| DFLLATAAAPKVLAI | 56 | P0C646 | |
| ALDKDNNTPLLFAII | 161 | Q5SQ80 | |
| ALLALKFILAFAIPD | 601 | Q9NW15 | |
| KTLLDPFQFVRNSLA | 71 | Q6NXN4 | |
| LQAVNFPFLVKLEFS | 96 | P17612 | |
| LFLELPSCLSFVNAK | 631 | Q9BYH8 | |
| DLVENKFLLPSANSF | 361 | Q14500 | |
| DLLNNKLVTLPVSFA | 91 | Q96AG4 | |
| APNFSFLSLLANLLL | 91 | Q8TDU6 | |
| LILADKLQGPFSFEL | 301 | Q8N158 | |
| VLDLLNFLKPAFVTS | 551 | Q6ZRQ5 | |
| LFLKAPVNTAELTDL | 81 | Q9P287 | |
| NQLERFKLSALAPLF | 216 | Q8IY21 | |
| PDLAFSFLLILALGQ | 6 | Q9NR23 | |
| SFALALLLPVFLAVA | 61 | Q8WUY8 | |
| FNELNDLFKAACLPL | 31 | P13796 | |
| LVKIFSFLPTRALAA | 481 | Q6PJ61 | |
| EKLLAAFPNLANLSR | 411 | Q6PID8 | |
| LPFSESLNKFLAVLE | 416 | Q8IXT1 | |
| LASLKRAFEAANLPA | 196 | Q86SG6 | |
| RAFEAANLPALVLKI | 201 | Q86SG6 | |
| LEAASFLQILPVLDF | 126 | Q9P2J3 | |
| LKLPFERLAFVLSSN | 191 | Q9P2J3 | |
| KNPASLLFSLFEAIN | 291 | P09848 | |
| LFFSGLSKPIALALD | 1096 | O75581 | |
| ETFDFSALALLLQIP | 1086 | Q13136 | |
| ALTLALNKISSIPDF | 181 | Q9BXB1 | |
| SNLLAQSFILLKPVF | 566 | Q9UGJ1 | |
| FLLKLVNDIFTFVSP | 326 | Q92887 | |
| TFVSPQLLKLLISFA | 336 | Q92887 | |
| LEFLLRLIQAPSKFA | 281 | Q9UIX4 | |
| APALDFSLKLFAKEV | 276 | Q15274 | |
| FGKQAALDPFILLNL | 206 | P23471 | |
| SFVDPLLQFESQLKI | 51 | Q5TGP6 | |
| LAVSKFLLAFLVPLA | 206 | Q9Y5Y4 | |
| PVLFAKAAQIFITEL | 66 | Q13952 | |
| ALADLAVLLTAPFFL | 61 | Q15722 | |
| VDLADKLLQVASPFL | 1046 | O75694 | |
| LKTKPRFDFANLALA | 111 | Q8TAX0 | |
| QPLKVLGFAAFFALV | 1871 | Q7Z442 | |
| EKLFPLFLSILDGAQ | 221 | Q5TIA1 | |
| FLIKIAAIDNGLAFP | 336 | Q8TCG2 | |
| SAVAFFVPSNLLLLL | 291 | Q96RI0 | |
| DLLFFEKAPSRQISL | 106 | Q15390 | |
| ELATLPKRAQLAAAF | 3196 | Q8NCM8 | |
| ALDKDNNTPLLFAII | 161 | Q5VUR7 | |
| ILKIQSPLFTLDANA | 2761 | P04114 | |
| AAALFPEFLKELAAL | 1006 | Q05DH4 | |
| FASGQLLKFLPAAVA | 66 | Q01638 | |
| ARAILDFPDKLNFST | 196 | Q4G0P3 | |
| LQAIDFPFLVKLQFS | 96 | P22612 | |
| KFAATPSLALFVNLK | 216 | Q14185 | |
| AALLNSFPTIFDELL | 786 | Q8IZD9 | |
| LDFLNNLEPKFITLA | 876 | Q14574 | |
| PFLLFSANLKRELAG | 36 | P24387 | |
| ALAFLAEAPAQAQKI | 76 | Q8NHY3 | |
| FLFNDFLLLTQITKP | 1481 | Q15811 | |
| SILFFSLADLANIEP | 3211 | Q8WXX0 | |
| PLLKAFAQAAAFLRQ | 696 | Q6NUI2 | |
| LKDFAAFLLPEQALA | 1686 | Q3T8J9 | |
| TFQLEVPKAFAASLL | 1701 | O75165 | |
| ISRAAFPLAFLIFNI | 421 | P23416 | |
| TLLPFAEAEAFLKKA | 816 | Q3KQU3 | |
| LFLLRDSQSNPKAFV | 516 | Q13322 | |
| AAFKSLNLPLQITLS | 71 | Q9BZJ6 | |
| DLLIQNEFFAPASLL | 86 | Q9NWZ3 | |
| SLLKNFPQTALVSFA | 311 | Q8N766 | |
| TIFKNAEFLVLTLNP | 416 | Q8NDH2 | |
| KPLLFDHLAQLFFTS | 471 | Q92674 | |
| KFLTVFLAIPLAFIA | 86 | P51636 | |
| FLLLINSLASKDFSP | 306 | P37059 | |
| AHLALLVAKNISFFP | 886 | Q9UHW9 | |
| LLVDFLAFPQKFIDL | 76 | Q6UVJ0 | |
| AINLLPLLFSQDFAK | 696 | Q9BXW9 | |
| KAPFLLNFSVERLDN | 246 | Q96E29 | |
| LKNLSFLDVFLVSVP | 61 | Q96R54 | |
| PALLREAENFTLFIK | 176 | P51575 | |
| KPALSFLFLSNLFLA | 386 | Q92521 | |
| DLVENKFLLPSANSF | 361 | B7U540 | |
| ANLIKELIDDFIFPA | 1456 | Q93008 | |
| QDLLDSFLSFFPELK | 481 | Q9HAU8 | |
| KRVPFLVLAAVSLFD | 241 | Q16572 | |
| ALLLLAVAKPFSAAA | 256 | Q16572 | |
| IAEFKLIPGLNNLFD | 411 | Q8TEL6 | |
| VALSSLKNIFTPLLF | 441 | Q8NDZ6 | |
| KIDPFEDLSFNLLAV | 1321 | O43426 | |
| QFSKLNLALFPRLVS | 216 | Q86VH5 | |
| IAVFLSLLPLNFFIS | 456 | O95255 | |
| EAFNLAFAELRKLLP | 91 | Q02577 | |
| NVSFVLVPFKVLDLL | 211 | Q16842 | |
| LLINKPDGTFLLRFS | 606 | P51692 | |
| TFLARQLAKPDNTLF | 836 | Q8N3P4 | |
| FISEPLFKLSLAKFD | 36 | O95969 | |
| NLINPSSLLELFFEL | 111 | Q9NVU7 | |
| KVEKLTLDNAAFPFL | 531 | P02786 | |
| LAQLVPFARAKDLSV | 1326 | O60287 | |
| TAILVKVQLDALPFF | 126 | Q99808 | |
| TKAAPILFASAALAL | 711 | Q7L0J3 | |
| LLINKPDGTFLLRFS | 606 | P42229 | |
| VLLLNIAFLLSPAFA | 291 | Q8IZF4 | |
| AVFSLAIKLQPSIIF | 176 | Q8NBU5 | |
| AISAVLAKPFIFADK | 121 | O14967 | |
| FFLNDQTLEFLKIPS | 116 | Q9HBJ8 | |
| LSFPISKLLDFFLGQ | 316 | Q6P4Q7 | |
| ANFFPKKLLELDSFL | 31 | P61289 | |
| KILLCLANQFPDISF | 116 | Q9ULP9 | |
| VLDAFALPLTNLFKA | 176 | P55060 | |
| IAPFVEILLTNLFKA | 546 | P55060 | |
| FLSNKFTDALELLRP | 146 | Q5VTQ0 | |
| LNNFQRAFLLASKAP | 56 | A2A3L6 | |
| FSADAEKVTPLLQLL | 591 | Q9UJ98 | |
| PLKFRVLFANLAALF | 171 | Q9NR77 | |
| RFTQPKEAEAFLLSL | 721 | Q9UBZ9 | |
| LFQASAFAFLVPAKA | 106 | Q9UHI7 | |
| AFAFLVPAKAILALE | 111 | Q9UHI7 | |
| PNANLVKTLVFFFLE | 456 | Q8N3U4 | |
| FVAILLFGSNFVPLK | 16 | Q7Z5S9 | |
| LLLFVADAAFTEVPK | 21 | A6NLU5 | |
| AFALAKEKAPSIIFI | 271 | P17980 | |
| QLFPDNFAKREILSL | 116 | Q9Y4K3 | |
| LFLAASLGPVAAFKV | 21 | Q9H7M9 | |
| FTAFPNLAKTALEIL | 521 | Q8IZ13 | |
| FEQLLAVLPAASKNL | 511 | Q8IZH2 | |
| FDLAVLELASPLAFN | 591 | Q7Z410 | |
| AASFKELPANSVLLI | 351 | Q8N9R8 | |
| LAAVTVFLNSLTPKF | 66 | Q8TDW4 | |
| AIPNLVIFAVLLFFS | 201 | Q9H0V1 | |
| TAVTEQLQLLPLFFK | 1591 | Q14997 | |
| DLTVALANPIKFFSA | 811 | Q00722 | |
| FILSADFPALVVKAS | 136 | P22102 | |
| VLAAGSPFFQDKLLL | 121 | Q9HC78 | |
| SSIVKNLNFIPFDIF | 1826 | Q7Z7G8 | |
| LPSLFAAFNVVLLVF | 26 | Q8WVZ1 | |
| FLLHDPSNFLKTALF | 161 | Q8N3G9 | |
| LPFFAAVEVLEKSLF | 396 | Q9H598 | |
| KEELAVLLLQSDPFF | 131 | Q7Z2W4 | |
| SDAFFLNLGAALLKL | 431 | Q14139 | |
| SILFDPNDAFTLKLE | 61 | Q9BY64 | |
| FLPLGFALKALVSFS | 246 | Q9H9Y6 | |
| LNPLLASFFSKVLSI | 116 | Q5H9R7 | |
| PLSDLSLAVQLFAKN | 391 | Q9Y4A5 | |
| GDNLLPFLRKFIASF | 1686 | O60293 | |
| LFPLVVDKFLFVDAD | 1346 | Q9NYU2 | |
| QTDLASLAFIPLAFL | 356 | Q8NBN3 | |
| LLEPFSKLLSFVIQN | 2216 | Q9P2D8 | |
| LLLPSFCKFQLQLSS | 306 | Q7Z570 | |
| KFLAQILTAFPALRF | 576 | P57678 | |
| PKDVANFFLLLLVLA | 86 | Q53FP2 |